Bone Marrow Transplant
Bone Marrow Transplant
We’re here for you. Call us at 844-346-7222 or
find a clinical trial
If you have any questions or are interested in participating in one of our Clinical Trials, please take note of the associated protocol number and contact our team at (201) 518-3587, or email us at email.
30
Clinical Trials
Bone Marrow Transplant
N/A
Enrolling
nct/study# N/A / NGS-AML-ALLO
Dynamic Changes in Pre- and Post-Transplant NGS MRD Status For Prediction of the Allogeneic Stem Cell Transplant Outcome in Patients with AML
Learn More
Bone Marrow Transplant
N/A
Enrolling
nct/study# NCT01166009 / NMDP-HSCT-DATABASE
A Research Database for Hematopoietic Stem Cell Transplantation and Marrow Toxic Injuries
Learn More
Bone Marrow Transplant
N/A
Enrolling
nct/study# N/A / CV-EVENTS-RIC-PTCY
Multicenter Study to Evaluate Incidence and Outcomes of Cardiovascular Events in Adult Reduced Intensity Conditioning Allogeneic Hematopoietic Cellular Transplantation Recipients Receiving Post-Transplantation Cyclophosphamide
Learn More
Bone Marrow Transplant
Phase II
Enrolling
nct/study# NCT06665100 / PUL-042-207
A Phase 2 Multiple Dose Study to Evaluate the Efficacy and Safety of PUL-042 Inhalation Solution in Reducing Lower Respiratory Tract Complications in Patients with Hematologic Malignancies and Recipients of Hematopoietic Stem Cell Transplantation (HSCT) with Documented Viral Infections with Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Virus (RSV)
Learn More
Bone Marrow Transplant
Phase II
Enrolling
nct/study# NCT07214688 / FLU-TBI-800-PTCY
A Phase 2 Study of Fludarabine and Intermediate Dose Total Body Irradiation (800 cGy) Followed by Post-Transplant Cyclophosphamide in Patients Aged 18-65 Undergoing Allogeneic Stem Cell Transplant for Hematologic Malignancies
Learn More
Bone Marrow Transplant
N/A
Enrolling
nct/study# N/A / SAMPLE-REPOSITORY-02-05-120
A Sample repository for Allogeneic unrelated HSCT
Learn MoreWe are here for you
For more information or to schedule an appointment, call (844) 346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.